Skip to content

Study · Not a test of the peptide alone · 2013

1 result

A comparative protease stability study of synthetic macrocyclic peptides that mimic two endocrine hormones.

Ferrie JJ, Gruskos JJ, Goldwaser AL, Decker ME, Guarracino DA

Bioorganic & medicinal chemistry letters22 Dec 2012Cited by 16 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Oxytocin.

  1. 01LabNot a test of Oxytocin aloneIn vitro (cell-free)Other

    In protease digestion assays, synthetic macrocyclic mimics of oxytocin and vasopressin degraded less and/or more slowly than the parent hormones, oxytocin included, and a linear control peptide.

    In plain wordsIn lab tests, synthetic copies of oxytocin and vasopressin broke down less or more slowly than the natural hormones.

    Peptide
    Oxytocin
    Outcome
    Not applicableProtease stability of macrocyclic oxytocin mimic versus parent hormone
    Study

    n: not reported in source

    pepsin, alpha-chymotrypsin and pronase digestion assay with glutathione
    Comparator
    Parent hormones and a linear control peptide
    Outcome group
    Formulation, delivery and stability · Pharmacology

    Source sentences

    Summary
    Subsequently, we discovered each of our mimics withstood protease treatment with less degradation and/or a slower rate of degradation as compared to both parent hormones and a linear control peptide.
    1 context sentence
    Summary · context
    Making notable changes to the overall structure and composition of the parent hormones, we synthesized the mimics and tested their durability against treatment with three proteases chosen for their specificity: pepsin, alpha-chymotrypsin, and pronase.

    In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.